Institut Curie Site Paris

Paris 75005

0 studies enrolling now · 2 studies all time

What they study most

Estrogen Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer, Locally Advanced or Metastatic Breast Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) — Running, not enrolling
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling